{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:46:19Z","timestamp":1783629979062,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral atrophy is a key finding in patients with dementia and usually determined on MRI. We tested whether cerebral atrophy can be imaged with FDG PET by applying deformation-based morphometry (DBM). We retrospectively identified 26 patients with a biomarker-supported clinical diagnosis of Alzheimer\u2019s disease (AD) who had received FDG PET on a fully-digital PET\/CT system and structural MRI and compared them to 13 healthy elderly controls (HEC). We performed DBM with FDG PET data (FDG-DBM). As a reference standard for determining atrophy we used voxel-based morphometry of MRI data (MRI-VBM). For conventional analysis of hypometabolism, scaled FDG PET scans (reference: brain parenchyma) were compared between groups. Receiver operating characteristic (ROC) analyses were performed. ROI read-outs were tested for associations with cognitive test performance. FDG-DBM showed abnormalities in AD mainly in the bilateral hippocampi. Similarly, MRI-VBM showed hippocampal atrophy. By contrast, conventional FDG PET analysis revealed reduced bilateral temporo-parietal FDG uptake (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05, FWE-corrected). FDG-DBM measures of the hippocampus significantly separated AD from HEC with an AUC of 0.81; MRI-VBM achieved an AUC of 0.87; the difference between the two ROC curves was not significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.40). Whereas FDG uptake of the hippocampus did not separate AD from HEC, FDG uptake of the Landau Meta-ROI achieved an AUC of 0.88. Verbal memory was significantly associated with FDG-DBM measures of the hippocampus (<jats:italic>p<\/jats:italic>\u2009=\u20090.009), but not of the Landau Meta-ROI (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.1). The opposite held true for conventional FDG uptake (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.1 and <jats:italic>p<\/jats:italic>\u2009=\u20090.001, respectively). Hippocampal atrophy in AD can be detected by applying DBM to clinical, fully-digital FDG PET. It correlates with cognitive performance and might constitute a biomarker of neurodegeneration that is complementary to conventional FDG PET analysis of regional hypometabolism.<\/jats:p>","DOI":"10.1038\/s41598-024-70380-z","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T20:17:21Z","timestamp":1724876241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-8935","authenticated-orcid":false,"given":"Lars","family":"Frings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna","family":"Blazhenets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"70380_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1053-8119(03)00041-7","volume":"18","author":"GB Karas","year":"2003","unstructured":"Karas, G. B. et al. A comprehensive study of gray matter loss in patients with Alzheimer\u2019s disease using optimized voxel-based morphometry. Neuroimage 18, 895\u2013907 (2003).","journal-title":"Neuroimage"},{"key":"70380_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1523\/JNEUROSCI.3732-07.2008","volume":"28","author":"P Pieperhoff","year":"2008","unstructured":"Pieperhoff, P. et al. Deformation field morphometry reveals age-related structural differences between the brains of adults up to 51 years. J Neurosci 28, 828\u2013842 (2008).","journal-title":"J Neurosci"},{"key":"70380_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/RLU.0000000000002960","volume":"45","author":"C Ozden","year":"2020","unstructured":"Ozden, C. et al. FDG uptake in the basal forebrain as measured by digital high-resolution PET is a promising marker of basal forebrain degeneration in the lewy body disease spectrum: A pilot study. Clin Nucl Med 45, 261\u2013266 (2020).","journal-title":"Clin Nucl Med"},{"key":"70380_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2012.02.010","volume":"316","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. Voxelwise meta-analysis of gray matter anomalies in Alzheimer\u2019s disease and mild cognitive impairment using anatomic likelihood estimation. J Neurol Sci 316, 21\u201329 (2012).","journal-title":"J Neurol Sci"},{"key":"70380_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnagi.2011.00010","volume":"3","author":"ML Schroeter","year":"2011","unstructured":"Schroeter, M. L. & Neumann, J. Combined imaging markers dissociate Alzheimer\u2019s disease and frontotemporal lobar degeneration: An ALE meta-analysis. Front Aging Neurosci 3, 10 (2011).","journal-title":"Front Aging Neurosci"},{"key":"70380_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/brain\/awy292","volume":"142","author":"RR Darby","year":"2019","unstructured":"Darby, R. R., Joutsa, J. & Fox, M. D. Network localization of heterogeneous neuroimaging findings. Brain 142, 70\u201379 (2019).","journal-title":"Brain"},{"key":"70380_CR7","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2967\/jnumed.107.042820","volume":"48","author":"I Matsunari","year":"2007","unstructured":"Matsunari, I. et al. Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer\u2019s disease: Aging effect on diagnostic performance. J Nucl Med 48, 1961\u20131970 (2007).","journal-title":"J Nucl Med"},{"key":"70380_CR8","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3174\/ajnr.A3113","volume":"33","author":"JA Maldjian","year":"2012","unstructured":"Maldjian, J. A. & Whitlow, C. T. Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited. AJNR Am J Neuroradiol 33, 1975\u20131982 (2012).","journal-title":"AJNR Am J Neuroradiol"},{"key":"70380_CR9","first-page":"195","volume":"77","author":"M Berres","year":"2000","unstructured":"Berres, M., Monsch, A. U., Bernasconi, F., Thalmann, B. & Stahelin, H. B. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer\u2019s disease. Stud Health Technol Inform 77, 195\u2013199 (2000).","journal-title":"Stud Health Technol Inform"},{"key":"70380_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris, J. C. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 39, 1159\u20131165 (1989).","journal-title":"Neurology"},{"key":"70380_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2967\/jnumed.119.231407","volume":"61","author":"I Speck","year":"2020","unstructured":"Speck, I. et al. (18)F-FDG PET imaging of the inferior colliculus in asymmetric hearing loss. J Nucl Med 61, 418\u2013422 (2020).","journal-title":"J Nucl Med"},{"key":"70380_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.neuroimage.2004.12.034","volume":"25","author":"SB Eickhoff","year":"2005","unstructured":"Eickhoff, S. B. et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25, 1325\u20131335 (2005).","journal-title":"Neuroimage"},{"key":"70380_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archneur.60.7.989","volume":"60","author":"RI Scahill","year":"2003","unstructured":"Scahill, R. I. et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 60, 989\u2013994 (2003).","journal-title":"Arch Neurol"},{"key":"70380_CR14","doi-asserted-by":"crossref","unstructured":"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging I (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32:1207\u20131218","DOI":"10.1016\/j.neurobiolaging.2009.07.002"},{"key":"70380_CR15","doi-asserted-by":"crossref","unstructured":"Jack CR, Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 14:535\u2013562","DOI":"10.1016\/j.jalz.2018.02.018"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70380-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T20:22:06Z","timestamp":1724876526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70380-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70380"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70380-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PTM received honoraria from GE (presentation, consultancy) and Philips (presentation). H.U. is co-editor of Clinical Neuroradiology, member of the Advisory Board of Biogen and received honoraria for lectures from Biogen, Eisai, and mbits. All other authors report no competing interests. All declared interests are outside of the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20030"}}